Asia-Pacific Molecular Point of care Testing (Using NAAT) Market to 2032
Overview
The Asia-Pacific Molecular Point of care Testing (Using NAAT) Market is expected to reach a 8.44 USD Billion by 2032 and is projected to grow at a CAGR of 17.90% from 2025 to 2032.
Revenue, 2024 (USD Billion)
3.04
Forecast, 2032 (USD Billion)
8.44
CAGR, 2024 - 2032
17.90%
Report Coverage
Asia-Pacific
Asia-Pacific Molecular Point of care Testing (Using NAAT) Market 2018-2032 USD Billion
Asia-Pacific Molecular Point of care Testing (Using NAAT) Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 3.04 USD Billion
- Projected Market Size (2032): 8.44 USD Billion
- CAGR (2025-2032): 17.90%
Key Findings of Asia-Pacific Molecular Point of care Testing (Using NAAT) Market
- The Asia-Pacific Molecular Point of care Testing (Using NAAT) Market was valued at 8.44 USD Billion in 2024.
- The Asia-Pacific Molecular Point of care Testing (Using NAAT) Market is likely to grow at a CAGR of 17.90% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Prescription-Based Testing in Mode of Testing Segment accounted for the largest share of the market with a revenue of 2.88 USD Billion
- The fastest growing segment Direct Sales in Distribution Channel Segment grew Fastest with a CAGR of 19.80% during the forecast period from 2024 to 2032.
Asia-Pacific Molecular Point of care Testing (Using NAAT) Market Scope
Asia-Pacific Molecular Point of care Testing (Using NAAT) Market Segmentation & Scope
Distribution Channel
- Online Sales
- Third Party Distributor
- Direct Sales
Indication
- Others
- Gastrointestinal Tract Infections Testing
- Sexually Transmitted Infection (STI) Testing
- Respiratory Infections Testing
Product
- Instruments
- Consumables & Reagents
Mode of Testing
- OTC Testing
- Prescription-Based Testing
End User
- Assisted Living Facilities
- Homecare
- Others
- Ambulatory Center
- Clinics
- Hospital
- Laboratories
Asia-Pacific Molecular Point of care Testing (Using NAAT) Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 3.04 USD Billion |
| Market Value in 2032 | 8.44 USD Billion |
| CAGR (2025-2032) | 17.90% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel, Indication, Product, Mode of Testing, End User |
Regional Insights:
-
Leading Market (2024-2032): Asia-Pacific, leading in terms of revenue 3.04 USD Billion in 2024
- Key Country: Singapore, leading in terms of revenue with value of 1,250.21 USD Million in 2024.
Segments and Scope
-
Asia-Pacific Molecular Point of care Testing (Using NAAT) Market to 2032, By Distribution Channel
- Direct Sales is the largest segment in Asia-Pacific Molecular Point of care Testing (Using NAAT) Market to 2032 with a revenue of 1.86 USD Billion in the year 2024.
- Direct Sales is the Fastest growing segment in Asia-Pacific Molecular Point of care Testing (Using NAAT) Market to 2032 with a Growth rate of 19.80 % in forecast period 2025-2032.
-
Asia-Pacific Molecular Point of care Testing (Using NAAT) Market to 2032, By Indication
- Respiratory Infections Testing is the largest segment in Asia-Pacific Molecular Point of care Testing (Using NAAT) Market to 2032 with a revenue of 1.95 USD Billion in the year 2024.
- Respiratory Infections Testing is the Fastest growing segment in Asia-Pacific Molecular Point of care Testing (Using NAAT) Market to 2032 with a Growth rate of 19.26 % in forecast period 2025-2032.
-
Asia-Pacific Molecular Point of care Testing (Using NAAT) Market to 2032, By Product
- Consumables & Reagents is the largest segment in Asia-Pacific Molecular Point of care Testing (Using NAAT) Market to 2032 with a revenue of 2.34 USD Billion in the year 2024.
- Consumables & Reagents is the Fastest growing segment in Asia-Pacific Molecular Point of care Testing (Using NAAT) Market to 2032 with a Growth rate of 18.27 % in forecast period 2025-2032.
-
Asia-Pacific Molecular Point of care Testing (Using NAAT) Market to 2032, By Mode of Testing
- Prescription-Based Testing is the largest segment in Asia-Pacific Molecular Point of care Testing (Using NAAT) Market to 2032 with a revenue of 2.88 USD Billion in the year 2024.
- Prescription-Based Testing is the Fastest growing segment in Asia-Pacific Molecular Point of care Testing (Using NAAT) Market to 2032 with a Growth rate of 18.17 % in forecast period 2025-2032.
-
Asia-Pacific Molecular Point of care Testing (Using NAAT) Market to 2032, By End User
- Laboratories is the largest segment in Asia-Pacific Molecular Point of care Testing (Using NAAT) Market to 2032 with a revenue of 2.23 USD Billion in the year 2024.
- Laboratories is the Fastest growing segment in Asia-Pacific Molecular Point of care Testing (Using NAAT) Market to 2032 with a Growth rate of 18.82 % in forecast period 2025-2032.
Asia-Pacific Molecular Point of care Testing (Using NAAT) Market Company Share Analysis
| Company Name |
|
||
| Thermo Fisher Scientific Inc. | |||
| Abbott | |||
| Hologic, Inc. | |||
| Danaher | |||
| F. Hoffmann-La Roche Ltd. | |||
Asia-Pacific Molecular Point of care Testing (Using NAAT) Market Geographical Sales Distribution, 2018-2032 USD Billion
Asia-Pacific Molecular Point of care Testing (Using NAAT) Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Asia-Pacific Molecular Point of care Testing (Using NAAT) Market is segmented based on Segmentation Distribution Channel, Indication, Product, Mode of Testing, End User.
Asia-Pacific Molecular Point of care Testing (Using NAAT) Market was valued at USD 3.04(Revenue in USD Billion) in 2022.
Asia-Pacific Molecular Point of care Testing (Using NAAT) Market is projected to grow at a CAGR of 17.90% during the forecast period of 2024 to 2032.
The Prescription-Based Testing segment is expected to dominate the Asia-Pacific Molecular Point of care Testing (Using NAAT) Market, holding a largest market share of 2.88 USD Billion in 2024
Coming Soon....
Asia-Pacific Molecular Point of care Testing (Using NAAT) Market Scope
Asia-Pacific Molecular Point of care Testing (Using NAAT) Market Segmentation & Scope
Distribution Channel
- Online Sales
- Third Party Distributor
- Direct Sales
Indication
- Others
- Gastrointestinal Tract Infections Testing
- Sexually Transmitted Infection (STI) Testing
- Respiratory Infections Testing
Product
- Instruments
- Consumables & Reagents
Mode of Testing
- OTC Testing
- Prescription-Based Testing
End User
- Assisted Living Facilities
- Homecare
- Others
- Ambulatory Center
- Clinics
- Hospital
- Laboratories
Frequently Asked Questions
The Asia-Pacific Molecular Point of care Testing (Using NAAT) Market is segmented based on Segmentation Distribution Channel, Indication, Product, Mode of Testing, End User.
Asia-Pacific Molecular Point of care Testing (Using NAAT) Market was valued at USD 3.04(Revenue in USD Billion) in 2022.
Asia-Pacific Molecular Point of care Testing (Using NAAT) Market is projected to grow at a CAGR of 17.90% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Molecular Point of care Testing (Using NAAT) Market for final year is USD 8.44 (USD Billion).
Asia-Pacific Molecular Point of care Testing (Using NAAT) Market Company Profiling
Frequently Asked Questions
The Asia-Pacific Molecular Point of care Testing (Using NAAT) Market is segmented based on Segmentation Distribution Channel, Indication, Product, Mode of Testing, End User.
Asia-Pacific Molecular Point of care Testing (Using NAAT) Market was valued at USD 3.04(Revenue in USD Billion) in 2022.
Asia-Pacific Molecular Point of care Testing (Using NAAT) Market is projected to grow at a CAGR of 17.90% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Molecular Point of care Testing (Using NAAT) Market for final year is USD 8.44 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.